Elaine Irving

Senior Clinical Development Director, Immunology @GSK

Stevenage, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2020 — Present

Senior Clinical Development Director, Immunology @GSK

View department →

Stevenage, GB

Accountable for the clinical development and evidence generation plans for a late phase asset in systemic sclerosis and interstitial lung disease associated with connective tissue disease to support regulatory approval, payer access and physician/patient uptake decisions.• Defining the vision for the programme, seeking senior leader endorsement/investment through governance interactions• Leading the design of two phase 3 programmes through interactions with key external experts and regulatory agencies • Paediatric development plans• Leading the clinical and integrated evidence teams• Regulatory interactionsCo-lead of the ILD Disease Area Acceleration Team • Leading cross functional team to deliver CTD-ILD portfolio strategy

EDUCATION

1989 — 1993

The University of Edinburgh

BSc, Pharmacology

1993 — 1996

University of Glasgow

PhD, Neuroscience

ABOUT ELAINE IRVING

More than 25y industry experience spanning R&D, with a reputation for leading new areas of research, ambitious clinical development/evidence generation plans, and above asset indication level strategy. A track record of effective leadership and fostering new ways of working, including partnerships across public and private sectors, to accelerate the discovery and development of new medicines across Neurology, Respiratory and Immunology. Specialties: Autoimmune-ILD, Lupus, Systemic Sclerosis, Stroke and Alzheimer\'s Disease

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Elaine Irving — Senior Clinical Development Director, Immunology at GSK in Stevenage, GB | Unifers